Related Experiment Videos
[Amiodarone therapy in childhood: efficacy and side effects]
Giornale Italiano Di Cardiologia
|August 1, 1985
Summary
Amiodarone is an effective treatment for pediatric arrhythmias, with oral administration showing high success rates and manageable side effects, making it a safe first-choice option for infants.
Area of Science:
- Pediatric Cardiology
- Clinical Pharmacology
- Cardiac Electrophysiology
Context:
- Amiodarone is a widely used antiarrhythmic drug in adults.
- Its use in children is limited due to potential severe side effects like thyroid dysfunction and pulmonary fibrosis.
- However, recent evidence suggests a low incidence of adverse events and significant efficacy in pediatric populations.
Purpose:
- To evaluate the efficacy and safety of Amiodarone in treating supraventricular and ventricular arrhythmias in children.
- To compare the effectiveness of intravenous and oral administration routes.
- To identify and monitor potential side effects in the pediatric population.
Summary:
- A study assessed 27 children (mean age 6 years) with arrhythmias treated with intravenous or oral Amiodarone.
- Oral treatment demonstrated higher efficacy (77% completely effective) compared to intravenous (56% successful).
- Key side effects included photosensitivity (22%) and transient thyroid hormone fluctuations (86%), with rare instances of AV block and sinus node dysfunction.
Impact:
- Amiodarone is a safe and highly effective first-line treatment for pediatric arrhythmias, particularly in infants.
- The findings support the expanded use of Amiodarone in pediatric cardiology, with careful monitoring for side effects.
- This research provides crucial data for optimizing antiarrhythmic therapy in young patients.